Mostrando resultados 15 a 24 de 24
< Anterior
| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| openAccess | | 24-jun-2022 | Mitochondrial damage, revealed as key factor in cabozantinib efficacy against hepatocellular carcinoma, is potentiated by the BH3-mimetic navitoclax | Tutusaus, Anna CSIC ORCID; Cucarull, Blanca CSIC; Rider, Patricia CSIC ORCID; Cuño, Carlos CSIC ORCID; García de Frutos, Pablo CSIC ORCID ; Marí, Montserrat CSIC ORCID; Morales, Albert CSIC ORCID | póster de congreso |
| openAccess | | 24-sep-2020 | Mitochondrial Glutathione: Recent Insights and Role in Disease | Marí, Montserrat CSIC ORCID ; Gregorio, Estefanía de CSIC; Dios, Cristina de CSIC ORCID; Roca-Agujetas, Vicente CSIC ORCID; Cucarull, Blanca CSIC; Tutusaus, Anna CSIC ORCID; Morales, Albert CSIC ORCID; Colell Riera, Anna CSIC ORCID | artículo de revisión |
| openAccess |  | 2020 | Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models | Cucarull, Blanca CSIC; Tutusaus, Anna CSIC ORCID; Subías, Miguel CSIC; Stefanovic, Milica CSIC; Hernáez-Alsina, Tania; Boix, Loreto; Reig, Maria; García de Frutos, Pablo CSIC ORCID ; Marí, Montserrat CSIC ORCID ; Colell Riera, Anna CSIC ORCID; Bruix, Jordi; Morales, Albert CSIC ORCID | artículo |
| openAccess |  | 28-sep-2020 | Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis | Tutusaus, Anna CSIC ORCID; Marí, Montserrat CSIC ORCID ; Ortiz-Pérez, José T.; Nicolaes, Gerry A. F.; Morales, Albert CSIC ORCID; García de Frutos, Pablo CSIC ORCID | artículo |
| openAccess |  | 14-nov-2023 | Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice | Cuño-Gómiz, Carlos; Gregorio, Estefanía de CSIC; Tutusaus, Anna CSIC ORCID; Rider, Patricia CSIC ORCID; Andrés-Sánchez, Nuria; Colell Riera, Anna CSIC ORCID; Morales, Albert CSIC ORCID; Marí, Montserrat CSIC ORCID | artículo |
| closedAccess |  | 22-abr-2015 | Sorafenib effect on mitochondrial function provides a target for increasing hcc therapy efficacy | Tutusaus, Anna CSIC ORCID; Stefanovic, Milica CSIC; Fernández-Checa, José C. CSIC ORCID; Marí, Montserrat CSIC ORCID ; Morales, Albert CSIC ORCID | póster de congreso |
| closedAccess |  | 22-abr-2015 | Targeting glucosylceramide synthase increases sorafenib efficacy and evades sorafenib resistance in HCC models | Stefanovic, Milica CSIC; Tutusaus, Anna CSIC ORCID; Bárcena, Cristina CSIC ORCID; Martínez-Nieto, Guillermo A. CSIC; Marí, Montserrat CSIC ORCID ; García-Ruiz, Carmen CSIC ORCID ; Fernández-Checa, José C. CSIC ORCID; Morales, Albert CSIC ORCID | póster de congreso |
| openAccess |  | 22-ene-2016 | Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma | Stefanovic, Milica CSIC; Tutusaus, Anna CSIC ORCID; Martínez-Nieto, Guillermo A. CSIC; Bárcena, Cristina CSIC ORCID; Gregorio, Estefanía de CSIC; Barbero-Camps, Elisabet CSIC; Colell Riera, Anna CSIC ORCID; Marí, Montserrat CSIC ORCID ; García-Ruiz, Carmen CSIC ORCID ; Fernández-Checa, José C. CSIC ORCID; Morales, Albert CSIC ORCID | artículo |
| closedAccess |  | 15-abr-2016 | Targeting Mitochondrial Function with the BCL-2 Inhibitor ABT-263 Increases Therapy Efficacy and Evades Sorafenib Resistance | Morales, Albert CSIC ORCID; Tutusaus, Anna CSIC ORCID; Fernández-Checa, José C. CSIC ORCID; Marí, Montserrat CSIC ORCID ; Stefanovic, Milica CSIC | comunicación de congreso |
| openAccess | | 25-jun-2022 | The AXL inhibitor bemcentinib reduces inflammation and fibrosis by inducing a dynamic change in macrophages and CD8+ T cells subsets during experimental NASH | Grøndal, Sturla M.; Tutusaus, Anna CSIC ORCID; García de Frutos, Pablo CSIC ORCID ; Morales, Albert CSIC ORCID; Marí, Montserrat CSIC ORCID | póster de congreso |
